Diagnostic and Interventional Cardiology

Largest randomized trial of DynamX Bioadaptor to date with 2,400 patients enrolled, covering real-world population

Elixir Medical Completes Enrollment of INFINITY-SWEDEHEART Clinical Trial

July 13, 2023 — Elixir Medical, a developer of breakthrough cardiovascular technologies, announced enrollment completion ...

July 13, 2023

During the AIMed 2023 Summit, a panel of experts shared their personal perspective on what’s happening in artificial intelligence (AI), particularly with ChatGPT, and where they think these advances are going, in a panel discussion titled AI Foundations: 2023 Update of AI in Healthcare.

Feature | Artificial Intelligence | By Melinda Taschetta-Millane

Advances in Artificial Intelligence: Experts Share Their Views

During the AIMed 2023 Summit, a panel of experts shared their personal perspective on what’s happening in artificial ...

July 13, 2023

To move forward in artificial intelligence, it is critical for the medical community to learn to look at solutions in multiple ways to develop a deeper sense of duality

Feature | Artificial Intelligence | By Melinda Taschetta-Millane

Discovering the Paradox of Duality at AIMed 2023

The 2023 AIMed Global Summit focused on artificial intelligence (AI) in healthcare, and offered valuable insights into ...

July 12, 2023

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

CPR Therapeutics Inc. (CPR-T), a Vermont-based medical device start-up company, announced today that it has received three U.S. patents for inventions that will contribute to the development of their breakthrough technology for cardiopulmonary resuscitation.

News | Sudden Cardiac Arrest

CPR Therapeutics Inc. Receives Three Patents In One Week For Innovations In Cardiopulmonary Resuscitation Technology

July 12, 2023 — CPR Therapeutics Inc. (CPR-T), a Vermont-based medical device start-up company, announced today that it ...

July 12, 2023

A subgroup analysis of the HOST-IDEA randomized controlled trial showed efficacy differences of Ultrathin Strut DES

News | Stents Drug Eluting

Late-Breaking Study Data: BIOTRONIK’s Orsiro DES Outperforms Other Ultrathin Strut Drug-Eluting Stent

July 12, 2023 — In a late breaking trial session during EuroPCR 2023 in Paris, on behalf of the HOST-IDEA study ...

July 12, 2023

FIRE1 announced the start of the first U.S. clinical study of its remote heart failure monitoring system, designed to provide unique insights to the care team and alert to deteriorating patient conditions for the almost 10M Americans with HF

News | Remote Monitoring

First U.S. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study

July 11, 2023 — FIRE1 announced that the first U.S. patients have been successfully implanted with its FIRE1 System for ...

July 11, 2023

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

The U.S. Food and Drug Administration (FDA) has issued a Letter to Health Care Providers about updated information associated with paclitaxel-coated devices used to treat peripheral arterial disease (PAD)

News | Peripheral Artery Disease (PAD)

Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease Unlikely to Increase Risk of Mortality

July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information ...

July 11, 2023

In addition to the study, the company appoints a world-class stroke advisory board as part of its acute ischemic stroke initiatives

News | Cardiac Imaging

Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care

July 11, 2023 — Hyperfine, Inc., the groundbreaking medical device company that created the Swoop system, the world’s ...

July 11, 2023

US study seeking to confirm strong efficacy data reported in RED DESERT and SAHARA

News | Heart Failure

Sequana Medical Announces First Patient Enrolled in MOJAVE

July 10, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

July 10, 2023

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Leqvio can now be used earlier in LDL-C treatment as an adjunct to diet and statin therapy for patients who have not had a cardiovascular event but are at an increased risk of heart

News | Pharmaceuticals

FDA Approves Expanded Indication for Leqvio

July 10, 2023 — Novartis announced that the US Food and Drug Administration (FDA) has approved a label update for Leqvio ...

July 10, 2023

Innovative platform designed for more personalized, tailored management of heart failure patients

News | Heart Failure

Adona Medical’s Next-Generation Heart Failure Management Platform Showcased at CSI Frankfurt 2023 Conference

July 10, 2023 — Adona Medical, a Shifamed portfolio company that aims to deliver advanced interatrial shunting and ...

July 10, 2023

Coronary computed tomography angiography is a cheaper, less-invasive alternative to intravascular ultrasound in pharmaceutical clinical trials

Feature | Cardiac Imaging | By Matthew Jay Budoff, MD, FACC, FAHA

The Benefits of Coronary CTA in Pharmaceutical Clinical Trials

Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than ...

July 10, 2023

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

HCPCS code C9786 can now be used for billing artificial intelligence to aid the detection of Heart Failure with Preserved Ejection Fraction (HFpEF).

News | Heart Failure

CMS Establishes HCPCS code for Ultromics EchoGo Heart Failure

July 7, 2023 — Ultromics, a leading health technology company advancing a novel approach for detecting heart failure and ...

July 07, 2023

Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs when the heart beats so fast that the upper chambers of the heart quiver. This irregular heartbeat can lead to severe conditions, including heart failure, dementia and a fivefold increase in the risk of stroke

News | Atrial Fibrillation

Reduced Levels of FKBP5 Promote Atrial Fibrillation

July 7, 2023 — Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs ...

July 07, 2023

The goal of the new initiative is to build a national effort to diagnose and treat many more children

News | Pediatric Cardiology

A Model for Africa: Côte d’Ivoire Health Ministry Announces New Initiative to Become Self-Sufficient in Pediatric Cardiology Surgery

July 7, 2023 — Launched by Mitrelli Group, Menomadin Foundation, Save a Child’s Heart, Côte d’Ivoire Health Ministry and ...

July 07, 2023